• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Biden-Harris administration using taxpayer money to mask Medicare premium hikes before election: critics

by August 14, 2024
written by August 14, 2024

In a move critics say is designed to shield the Biden-Harris administration from election fallout, the administration has leveraged taxpayer funds to mask upcoming increases in Medicare premiums.

Under the Inflation Reduction Act (IRA), which was intended to cap out-of-pocket drug costs for Medicare beneficiaries, insurers are poised to significantly hike monthly premiums, with average bids for Part D plans expected to triple by 2025.

In response to potential voter backlash, the Centers for Medicare and Medicaid Services (CMS) rolled out a three-year ‘demonstration project’ to subsidize these premiums, aiming to keep them artificially low. However, despite the appearance of relief, some critics are saying that taxpayers will fund a dramatic increase in subsidies — from $30 per recipient per month in 2024 to $142.70 in 2025 — raising concerns about the long-term impact on government spending and debt. 

Former President Trump advisor Joe Grogan has criticized the maneuver, arguing that it merely shifts costs rather than providing real relief.

‘They’ve destroyed part D premiums,’ Grogan told Fox News Digital in an interview. ‘I’m not sure it’ll survive legal scrutiny if someone were to sue. Objectively, it shouldn’t be done. It’s just interjecting $5-10 billion of taxpayer dollars, while the taxpayers are paying the price 85 days before an election. It’s sickening.’

‘This is only going to get worse in 2025, 2026,’ Grogan continued. ‘The program is in a death spiral. They announced a three-year demo. It’s already broken. The demo is going to fail. Premiums are still going to go up.’

Paragon Health Institute, a health care research group, called the CMS demo plan a ‘fake, costly demonstration,’ in a recent analysis. 

‘Fearing the premium increases that the IRA redesign will impose on Part D plans, CMS has now launched a new voluntary, nationwide demonstration program that is neither a demonstration nor voluntary. Unlike this massive subsidization scheme, demonstrations are supposed to be limited in nature and test alternative features of program design,’ the institute wrote. ‘As a result of the IRA changes, insurers that don’t participate are expected to either be uncompetitive from a price perspective or face significant losses – hardly a choice for insurers.’

Research published by Fidelity, an investment research group, shows that a 65-year-old retiring today can expect to spend $165,000 on health care in retirement, a 5% increase from last year and more than double the estimate from 2002.

Yet, there appears to be a disconnect for many Americans between the actual projected cost of health care in retirement and how much they expect to spend on those expenses. The average American thinks they will spend about $75,000 on health care and other medical expenses, less than half of Fidelity’s calculation, according to the research.

The estimate assumes that an individual is enrolled in Medicare – including Part A and Part B, which cover most hospital care and doctor’s visits – and Part D, which covers prescription drugs. Other expenses such as Medicare premiums, over-the-counter medications, dental and vision care and other costs typically not covered by Medicare are ‘left to retirees to manage on their own,’ the report said.

As of April 2024, about 67.3 million Americans were enrolled in Medicare, according to the Centers for Medicare and Medicaid Services. Of those, about half were enrolled in a Medicare Advantage plan, while about 80% were covered by Medicare Part D.

‘They just want to get through the election,’ Grogan said. ‘They’re hoping after the election they can face it, but its gonna need to be dealt with in the next 12–18 months. They did not believe it would be this bad and its only gonna get worse.’ 

Americans are also dealing with a spike in the cost of prescription drugs, which has surged nearly 40% over the past decade, easily outstripping the pace of inflation. 

Fox News Digital has reached out to CMS for comment. 

Fox Business’ Megan Henney contributed to this report. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Oil and natural gas: oil price in retreat since Tuesday
next post
The dollar index under strong bearish pressure this week

related articles

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

US diplomatic facility in Iraq struck by drone

March 13, 2026

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

171 million travelers face airport delays as Democrats’...

March 13, 2026

FDA launches new AI-powered system to track drug...

March 13, 2026

Cornyn reverses on filibuster stance to push Trump’s...

March 13, 2026

DAVID MARCUS: Sen Thune has no idea how...

March 13, 2026

Trump touts 5-0 sweep by endorsed candidates in...

March 13, 2026

US destroys 16 Iranian mine boats as Strait...

March 13, 2026

House GOP urges Trump to choke off Iran...

March 13, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Partial government shutdown drags on as DHS funding talks stall

    February 16, 2026
  • Russia alleges attack on Putin residence as Ukraine denies claim ahead of Trump talks

    December 31, 2025
  • Ramaswamy warns GOP on several ‘hard realities’ to address before criticizing Harris: ‘Hurting our chances’

    July 26, 2024
  • US Prez Donald Trump says smartphone tariff relief was temporary, new duties coming

    April 14, 2025
  • Trump says US sank 10 ships in Iran strike, ‘last, best chance’ to act

    March 2, 2026

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025

Categories

  • Economy (829)
  • Editor's Pick (8,376)
  • Investing (1,192)
  • Stock (981)

Latest Posts

  • Why Trump is right to revitalize the Monroe Doctrine

    April 18, 2025
  • Musk unveils Tesla-xAI project ‘Macrohard’ to emulate software companies

    March 11, 2026
  • Arrest of Chinese nationals in swing state, Israel’s fight with Iran are ‘wake up’ call on CCP threat: experts

    June 21, 2025

Recent Posts

  • Israel warns it will go after Lebanon directly if cease-fire with Hezbollah collapses

    December 3, 2024
  • US Presidential Election: Harris, Trump & Debate

    August 1, 2024
  • Why AMD stock is surging over 2%

    March 9, 2026

Editor’s Pick

  • ‘Genocide can’t be ignored’: GOP lawmaker backs Trump’s threat of military action in Nigeria

    November 9, 2025
  • Bipartisan bill seeks to stop pharmacy middlemen from driving up drug costs for financial gain

    March 18, 2025
  • ‘Trump trade’ returns for second week as bitcoin, Tesla, stocks surge

    November 12, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock